Re: A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell Carcinoma: Editorial comment

Samir S. Taneja

doi:10.1016/j.juro.2012.08.167

Re: A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell Carcinoma: Editorial comment

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2146-2147
Number of pages	2
Journal	Journal of Urology
Volume	188
Issue number	6
DOIs	https://doi.org/10.1016/j.juro.2012.08.167
State	Published - Dec 2012

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2012.08.167

Cite this

@article{e6a8321cee00480391210751a01fba7a,

title = "Re: A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell Carcinoma: Editorial comment",

author = "Taneja, {Samir S.}",

year = "2012",

month = dec,

doi = "10.1016/j.juro.2012.08.167",

language = "English (US)",

volume = "188",

pages = "2146--2147",

journal = "Investigative Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Re

T2 - A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell Carcinoma: Editorial comment

AU - Taneja, Samir S.

PY - 2012/12

Y1 - 2012/12

UR - http://www.scopus.com/inward/record.url?scp=84869063113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869063113&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2012.08.167

DO - 10.1016/j.juro.2012.08.167

M3 - Comment/debate

C2 - 23141218

AN - SCOPUS:84869063113

SN - 0022-5347

VL - 188

SP - 2146

EP - 2147

JO - Investigative Urology

JF - Investigative Urology

IS - 6

ER -

Re: A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell Carcinoma: Editorial comment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this